ACAD
30.43
+0.34
+1.13%
AEMD
2.06
+0.01
+0.49%
APRI
1.08
-0.02
-1.82%
ARNA
24.05
+0.47
+1.99%
ATEC
1.725
-0.065
-3.631%
CNAT
6.04
0.00
0.00%
CRXM
0.169
0.00
0.00%
CYTX
1.11
-0.01
-0.89%
DXCM
69.52
-0.49
-0.70%
GNMK
12.05
-0.21
-1.71%
HALO
13.53
+0.27
+2.04%
ILMN
172.75
+0.78
+0.45%
INNV
0.116
-0.005
-4.132%
INO
6.01
0.00
0.00%
ISCO
1.23
-0.1
-7.52%
ISIS
57.56
0.00
0.00%
LGND
123.05
+2.36
+1.96%
LPTN
2.93
-2.93
-100.00%
MBVX
0.96
+0.03
+3.23%
MEIP
3.02
-0.05
-1.63%
MNOV
5.43
+0.12
+2.26%
MRTX
4.9
+0.25
+5.38%
MSTX
0.131
-0.007
-5.278%
NBIX
47.07
-0.72
-1.51%
NUVA
79.92
-1.19
-1.47%
ONCS
1.08
-0.04
-3.57%
ONVO
2.37
+0.05
+2.16%
OREX
2.47
-0.13
-5.00%
OTIC
18.9
+0.15
+0.80%
QDEL
37.71
-0.02
-0.05%
RCPT
231.96
0.00
0.00%
RGLS
0.98
+0.1
+11.36%
RMD
77
-1.03
-1.32%
SCIE
0
0.00
-14.2857%
SPHS
2.07
0.00
0.00%
SRNE
2.05
0.00
0.00%
TROV
0.96
-0.03
-3.03%
VICL
2.66
+0.01
+0.37%
VOLC
18
0.00
0.00%
ZGNX
13.4
-0.2
-1.47%
ACAD
30.43
+0.34
+1.13%
AEMD
2.06
+0.01
+0.49%
APRI
1.08
-0.02
-1.82%
ARNA
24.05
+0.47
+1.99%
ATEC
1.725
-0.065
-3.631%
CNAT
6.04
0.00
0.00%
CRXM
0.169
0.00
0.00%
CYTX
1.11
-0.01
-0.89%
DXCM
69.52
-0.49
-0.70%
GNMK
12.05
-0.21
-1.71%
HALO
13.53
+0.27
+2.04%
ILMN
172.75
+0.78
+0.45%
INNV
0.116
-0.005
-4.132%
INO
6.01
0.00
0.00%
ISCO
1.23
-0.1
-7.52%
ISIS
57.56
0.00
0.00%
LGND
123.05
+2.36
+1.96%
LPTN
2.93
-2.93
-100.00%
MBVX
0.96
+0.03
+3.23%
MEIP
3.02
-0.05
-1.63%
MNOV
5.43
+0.12
+2.26%
MRTX
4.9
+0.25
+5.38%
MSTX
0.131
-0.007
-5.278%
NBIX
47.07
-0.72
-1.51%
NUVA
79.92
-1.19
-1.47%
ONCS
1.08
-0.04
-3.57%
ONVO
2.37
+0.05
+2.16%
OREX
2.47
-0.13
-5.00%
OTIC
18.9
+0.15
+0.80%
QDEL
37.71
-0.02
-0.05%
RCPT
231.96
0.00
0.00%
RGLS
0.98
+0.1
+11.36%
RMD
77
-1.03
-1.32%
SCIE
0
0.00
-14.2857%
SPHS
2.07
0.00
0.00%
SRNE
2.05
0.00
0.00%
TROV
0.96
-0.03
-3.03%
VICL
2.66
+0.01
+0.37%
VOLC
18
0.00
0.00%
ZGNX
13.4
-0.2
-1.47%
Home » Archive by Category

Xconomy

Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M

March 1, 2017 – 6:40 am

Last month, Grail publicly spread word of intentions to raise more than $1 billion in an ambitious quest to develop a blood test that can diagnose and detect cancer at its earliest stages. Today, the…

[[Click headline to continue reading.]]

Former FDA Commissioners Califf, McClellan Talk Healthcare’s Future

March 1, 2017 – 3:57 am

The top spot at the FDA remains vacant, and the change in presidential power has some healthcare observers wondering about possible changes for the regulator. One month removed from serving as FDA…

[[Click headline to continue reading.]]

Blood Pressure Drug Trial Results Lift La Jolla Pharma Shares

February 27, 2017 – 8:18 am

La Jolla Pharmaceutical’s experimental drug to treat a deadly blood pressure condition hit its main goal in a Phase 3 clinical trial, boosting the company’s stock price by more than 75 percent on…

[[Click headline to continue reading.]]

Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More

February 24, 2017 – 3:30 am

A short week makes for a shorter roundup. As we’ve come to expect, however, there was no dearth of health and life-sciences news from Washington, D.C. A bipartisan group of Congress members who…

[[Click headline to continue reading.]]

Aiming At P53, Cancer’s Hard Target, PMV Pharma Raises $74M

February 22, 2017 – 9:24 am

PMV Pharmaceuticals is the latest startup to load up with cash in an attempt to home in on one of the toughest targets in cancer biology: the tumor suppressor protein known as p53. The company,…

[[Click headline to continue reading.]]

Cidara Antifungal Flunks in Phase 2 Clinical Trial, Sinking Shares

February 21, 2017 – 9:24 am

Cidara Therapeutics is halting work on an experimental topical antifungal drug designed to treat vaginal yeast infections after the compound wasn’t better than the current standard of care in a Phase…

[[Click headline to continue reading.]]

Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More

February 17, 2017 – 5:45 am

News may be coming out of Washington, DC, at a breakneck pace, but concrete plans regarding the future of the nation’s healthcare system, the FDA, and the pharmaceutical industry have been much…

[[Click headline to continue reading.]]

Dermata Secures $10M in Combined Financing for Skin Treatments

February 16, 2017 – 9:12 pm

[Corrected 2/17/17, 9:41 am to differentiate Silicon Valley Bank’s loan from private investment.] Dermata Therapeutics, a San Diego development-stage biotech advancing new treatments for…

[[Click headline to continue reading.]]

With $20M, UCSD Spinout Jecure To Press New Attack On NASH

February 15, 2017 – 4:55 am

[Updated 2/15/17, 8:10 pm ET. See below.] Liver disease is challenging for doctors because it can develop without symptoms, making diagnosis difficult without removing cells for examination. For…

[[Click headline to continue reading.]]

Dear Tom Price: Bundled Payments Help Patients and Reduce Costs

February 11, 2017 – 3:00 am

With all the talk of repealing Barack Obama’s Affordable Care Act (ACA), people have been taking a closer look at what the law has done for our healthcare system. It turns out the ACA is about a lot…

[[Click headline to continue reading.]]